Company intelligence / Profile preview

Growratio

Ownership: Private
Development stage: Commercial

Overview

GROW Group, through its GROW Pharma division, supplies a wide range of prescribed cannabis medicines across the UK. The company partners with global producers like Tilray and Aurora, offers its own branded oils/flowers, supports bespoke formulations for patients' needs, and provides educational resources for healthcare professionals. It collaborates on access projects to reduce costs for vulnerable populations. Clinical results per se are not published as it operates as a supplier/distributor rather than a drug developer.

Therapeutic areas: OncologyNeurologyOther
Modalities: Cannabis-based medicinal productSmall molecule
Industry: Non-Academic Healthcare

Partnerships

TilrayAuroraIntegro Medical ClinicLVL Health

Beyond the preview

Go deeper on Growratio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Growratio.

Explore the full profile